0001144204-12-003574.txt : 20120123
0001144204-12-003574.hdr.sgml : 20120123
20120123204002
ACCESSION NUMBER: 0001144204-12-003574
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120119
FILED AS OF DATE: 20120123
DATE AS OF CHANGE: 20120123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHARMACYCLICS INC
CENTRAL INDEX KEY: 0000949699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943148201
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: PHARMACYCLICS INC
STREET 2: 995 E ARQUES AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085-4521
BUSINESS PHONE: 408 774 0330
MAIL ADDRESS:
STREET 1: PHARMACYCLICS INC
STREET 2: 995 E ARQUES AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085-4521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAKER JULIAN
CENTRAL INDEX KEY: 0001087939
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26658
FILM NUMBER: 12540579
MAIL ADDRESS:
STREET 1: BAKER BROTHERS ADVISORS
STREET 2: 667 MADISON AVENUE, 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAKER FELIX
CENTRAL INDEX KEY: 0001087940
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26658
FILM NUMBER: 12540580
MAIL ADDRESS:
STREET 1: BAKER BROTHERS ADVISORS
STREET 2: 667 MADISON AVENUE, 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baker Brothers Life Sciences Capital (GP), LLC
CENTRAL INDEX KEY: 0001307729
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26658
FILM NUMBER: 12540581
BUSINESS ADDRESS:
STREET 1: 667 MADISON AVENUE
STREET 2: 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
BUSINESS PHONE: 212-339-5600
MAIL ADDRESS:
STREET 1: 667 MADISON AVENUE
STREET 2: 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
FORMER NAME:
FORMER CONFORMED NAME: Baker Biotech Capital III (GP), LLC
DATE OF NAME CHANGE: 20041103
4
1
form447614_20120123083920-.xml
X0304
4
2012-01-19
0
0000949699
PHARMACYCLICS INC
PCYC
0001307729
Baker Brothers Life Sciences Capital (GP), LLC
667 MADISON AVENUE, 21ST FLOOR
NEW YORK
NY
US 10065
0
0
1
0
0001087940
BAKER FELIX
667 MADISON AVENUE, 21ST FLOOR
NEW YORK
NY
US 10065
0
0
1
0
0001087939
BAKER JULIAN
667 MADISON AVENUE, 21ST FLOOR
NEW YORK
NY
US 10065
0
0
1
0
Common Stock
2012-01-19
4
P
0
22081
16.0682
A
7625736
I
Through Partnership
Common Stock
2012-01-19
4
P
0
10327
16.0686
A
7636063
I
Through Partnership
Common Stock
2012-01-19
4
P
0
2449
15.8091
A
7638512
I
Through Partnership
Common Stock
2012-01-20
4
P
0
178921
16.4096
A
7817433
I
Through Partnership
Common Stock
2012-01-20
4
P
0
69245
16.4338
A
7886678
I
Through Partnership
Common Stock
2012-01-20
4
X
0
16200
15
A
7902878
I
Through Partnership
Common Stock
2012-01-20
4
X
0
8700
15
A
7911578
I
Through Partnership
Common Stock
2012-01-23
4
P
0
43644
16.8975
A
7955222
I
Through Partnership
Common Stock
2012-01-23
4
P
0
72997
16.8784
A
8028219
I
Through Partnership
Common Stock
2012-01-23
4
P
0
45574
16.8399
A
8073793
I
Through Partnership
Call Option
15
2012-01-19
4
P
0
162
1.25
A
2012-01-19
2012-01-21
Common Stock
16200
162
I
Through Partnership
Call Option
15
2012-01-20
4
P
0
87
1.4976
A
2012-01-20
2012-01-21
Common Stock
8700
249
I
Through Partnership
Call Option
15
2012-01-20
4
X
0
162
1.25
D
2012-01-19
2012-01-21
Common Stock
16200
87
I
Through Partnership
Call Option
15
2012-01-20
4
X
0
87
1.4976
D
2015-01-20
2012-01-21
Common Stock
8700
0
I
Through Partnership
In addition to Baker Brothers Life Sciences Capital (GP), LLC, this Form 4 is being filed jointly by Julian C. Baker and Felix J. Baker, each of whom has the same business address as Baker Brothers Life Sciences Capital (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Because of certain relationships with other security holders of the Issuer, the Reporting Persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (Continued in footnote 2).
However, the Reporting Persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
Represents securities owned directly by Baker Brothers Life Sciences, L.P., the sole general partner of which is Baker Brothers Life Sciences Capital, L.P., a limited partnership the sole general partner of which is Baker Brothers Life Sciences Capital (GP),LLC. Julian C. Baker and Felix J. Baker are the controlling members of Baker Brothers Life Sciences Capital (GP), LLC.
/s/ Julian C. Baker, as Managing Member of Baker Brothers Life Sciences Capital (GP), LLC
2012-01-23
/s/ Julian C. Baker
2012-01-23
/s/ Felix J. Baker
2012-01-23